Neutrophilic dermatoses: a review of current treatment options.
about
SHP-1 and IL-1α conspire to provoke neutrophilic dermatoses.Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a child, associated with a rotavirus infection: a case reportDapsone in dermatology and beyondSkin manifestations of inflammatory bowel disease.[Sweet Syndrome: Clinical and pathologic study over 5 years].Neonatal Sweet's Syndrome Associated with Rectovestibular Fistula with Normal Anus.Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessPyoderma gangrenosum: An update.Histiocytoid Sweet's syndrome in a patient with myelodsyplastic syndrome: report and review of the literatureWhy dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.An evidence-based approach to diagnosis and management of cellulitis.Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease.Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.Neutrophilic dermatoses: an update.A Review and Proposed Approach to the Neutrophilic Dermatoses of Childhood.Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress.The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha.Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin.Pyoderma Gangrenosum after Deep Inferior Epigastric Perforator Breast Reconstruction: Systematic Review and Case Report.Sweet's syndrome: a clinical entity need to discriminate against acute haematogenous periprosthetic joint infection.Sweet's syndrome complicating ulcerative colitis: a rare association.Pediatric Sweet syndrome. A retrospective study.Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome.ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.Leukocyte adhesion deficiency-I with a novel intronic mutation presenting with pyoderma gangrenosum- like lesions.Suppression of Neutrophil-Mediated Tissue Damage-A Novel Skill of Mesenchymal Stem Cells.Nasal septal perforation associated with pyoderma gangrenosum.Management of cutaneous disorders related to inflammatory bowel disease.Eight-year old male patient with painful swelling and eruptions in the legs.Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation.Sweet's syndrome: diagnostic criteria revisited.Stem bark and flower extracts of Vismia cauliflora are highly effective antioxidants to human blood cells by preventing oxidative burst in neutrophils and oxidative damage in erythrocytes.Function and regulation of IL-1α in inflammatory diseases and cancer.Rash, Fever, and Pulmonary Hypertension in a 6-Year-Old Female.The safety of treatments used in pyoderma gangrenosum.T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.
P2860
Q33879997-E97D661D-8FF1-4364-9AD6-4CDDB56880FFQ34105151-3F7A503F-1337-438A-B495-920D7160488FQ34390020-58FE5F53-22AA-4D54-9B1F-AE05E97EF99AQ35740427-9E86BFCA-F456-45E6-A5B0-092E79948A85Q35831184-C0664C9C-0886-4026-91DD-808C6A56EECFQ35869168-8B835C63-3FC8-435C-9BC8-F4F3D902599DQ36234132-5581A059-5B99-4909-A8AF-CB8FA07426E9Q36349668-E3A3C73C-F337-4FD4-8998-D090C7FA2C16Q36592935-5EF3EF08-FBF3-4968-821A-E8D8AC5AF315Q38007011-53EAB72F-C5DC-4C24-9E6A-25B52086E8F5Q38010081-642FD189-4D07-4860-A911-1C02DC8674D5Q38075485-731EDB41-1B2F-4AF8-BD83-43685524C010Q38145354-D8388C6E-AE6D-44E4-9C80-726392599DA2Q38150741-83B2169D-E24C-4EC0-8D7B-1D2E33B5C082Q38242975-005C38A8-ACEC-41BA-9491-C6EDEBFEEF7CQ38366349-C9F6A68D-09EA-4024-992D-C57E2E22AC17Q38663608-4F09AB58-F5D6-4DE9-A882-D2F27619F3C8Q38721101-7DA53EF0-E2AA-44DA-9A38-E5A774A7D7EDQ38878817-1F65A5B9-5533-4445-84CE-646D287FBDA8Q38891976-E4A694BA-FCAF-40D8-8329-F0EF44500CEEQ38948602-10E4AF24-E692-4DA7-A285-77385E430071Q38955520-C66C867C-5872-4A9E-9B0F-135FEB6CFA86Q39308726-CFD86B85-D3E4-40FD-8F02-B192C6FDF3A0Q40040569-F9290540-203B-4E12-A2D8-0C2D0A077699Q40121922-B8526973-F39F-4EB1-882B-50C1A6946427Q40181300-F0C2FC21-3773-4402-9CFF-522E6E327C0EQ40328703-38B0DB69-0796-4B54-8DDB-2C91CC08A8E4Q41109922-67F34991-E1A1-4B24-9D1D-325747331793Q41331976-2481FE78-672D-4964-B89E-1D9C976D9662Q41524707-1A68F1A5-F29F-4760-91D7-7B487B30A442Q42064541-70075C63-2DDB-43D8-9AA6-1C7E76E92CB7Q42406766-008889DC-8B4E-4B4B-BBBA-0B7CD7F3E1EFQ42534613-F1C5C393-832E-479E-9F17-3D6FBEB9994BQ46429222-6BB8EA00-D778-4B75-A577-89512F32A8E3Q46694620-D30A136E-EB24-437D-AAA6-5FA7FC991D3EQ46744385-06625040-8F16-428D-AD71-75EABD5ADC15Q47285901-F14F8CDB-9042-4562-8A5F-B3B82C45A9ECQ47556197-BC5929F2-8F1A-468E-88D9-CBDFF469E13AQ47641664-C6B9A7EF-2D99-43AB-8152-7F5332EF8692Q48127326-6A6523C3-1ED7-4E61-B055-5F2E822EB0B6
P2860
Neutrophilic dermatoses: a review of current treatment options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neutrophilic dermatoses: a review of current treatment options.
@en
Neutrophilic dermatoses: a review of current treatment options.
@nl
type
label
Neutrophilic dermatoses: a review of current treatment options.
@en
Neutrophilic dermatoses: a review of current treatment options.
@nl
prefLabel
Neutrophilic dermatoses: a review of current treatment options.
@en
Neutrophilic dermatoses: a review of current treatment options.
@nl
P1476
Neutrophilic dermatoses: a review of current treatment options.
@en
P2093
Philip R Cohen
P304
P356
10.2165/11310730-000000000-00000
P577
2009-01-01T00:00:00Z
P5875
P6179
1040351641